NYT: Trump’s Aggressive Advocacy of Malaria Drug for Treating Coronavirus Divides Medical Community
Posted by Sinister Burt on April 7, 2020, 9:43 am
OK, it's the NYT, maybe not the most impartial source on trump, and it's a little tenuous (and they're not usually in the habit of talking about dodgy oligarchs' financial connections unless it suits some other, bigger oligarchs), but it's the sort of petty motivation that makes perfect sense to me regarding the orange narcissist - though even if his motivation here is genuinely about helping people not die, that itself would surely be based on his fear of not being re-elected. |
"...If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.
Some associates of Mr. Trump’s have financial interests in the issue. Sanofi’s largest shareholders include Fisher Asset Management, the mutual fund company run by Ken Fisher, a major donor to Republicans, including Mr. Trump. A spokesman for Mr. Fisher declined to comment.
Another investor in both Sanofi and Mylan, another pharmaceutical firm, is Invesco, the fund previously run by Wilbur Ross, the commerce secretary. Mr. Ross said in a statement Monday that he “was not aware that Invesco has any investments in companies producing” the drug, “nor do I have any involvement in the decision to explore this as a treatment.”
As of last year, Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi."